{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:12:53Z","timestamp":1793153573953,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreas"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>The objective of this study was to describe the periprocedural management of patients with well-differentiated neuroendocrine tumors with hepatic metastases who underwent liver-directed procedures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a retrospective review of patients with metastatic neuroendocrine tumors who underwent liver resection, ablation, or embolotherapy at a single center from 2012 to 2016. The primary outcome was occurrence of documented carcinoid crisis (CC) or hemodynamic instability (HDI), defined as 10 minutes or more of systolic blood pressure less than 80 or greater than 180 mm Hg, or pulse greater than 120 beats per minute.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified 75 patients who underwent liver resection\/ablation (n = 38) or embolotherapy (n = 37). Twenty-four patients (32%) experienced CC or HDI (CC\/HDI); CC occurred in 3 patients. No clinicopathologic or procedural factors, including procedure type, octreotide or long-acting somatostatin analog use, and history of carcinoid syndrome, were associated with CC\/HDI. Grades 2 to 4 complications were reported in 42% of patients who experienced CC\/HDI versus in 16% of patients who did not experience CC\/HDI (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>A significant portion of patients developed CC\/HDI, and these patients were more likely to develop severe postprocedural complications. Periprocedural octreotide use was not associated with lower CC\/HDI occurrence, but continued use is advised given its safety profile until additional studies definitively demonstrate lack of benefit.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mpa.0000000000001271","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T18:36:12Z","timestamp":1554489372000},"page":"496-503","source":"Crossref","is-referenced-by-count":35,"title":["Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases"],"prefix":"10.1097","volume":"48","author":[{"given":"Daniel H.","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Paciorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire K.","family":"Mulvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Fidelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhong","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Yale University, New Haven, CT; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric K.","family":"Nakakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Bergsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230822","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","article-title":"Carcinoid tumors","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"key":"bib2-20230822","first-page":"26","article-title":"The carcinoid crisis","volume":"315","year":"1964","journal-title":"Arch Intern Med"},{"key":"bib3-20230822","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.7314\/APJCP.2014.15.16.6679","article-title":"Somatostatin analogues do not prevent carcinoid crisis","volume":"15","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"bib4-20230822","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12630-013-0026-4","article-title":"A case of acute respiratory distress syndrome responsive to methylene blue during a carcinoid crisis","volume":"60","year":"2013","journal-title":"Can J Anaesth"},{"key":"bib5-20230822","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/oxfordjournals.ndt.a027221","article-title":"Acute renal failure associated with carcinoid crisis","volume":"11","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"bib6-20230822","first-page":"471","article-title":"Carcinoid crisis with fatal coronary spasm in a small localized peripheral bronchial carcinoid","volume":"65","year":"2010","journal-title":"Acta Cardiol"},{"key":"bib7-20230822","first-page":"487801","article-title":"Reversible right-sided heart failure secondary to carcinoid crisis","volume":"2013","year":"2013","journal-title":"Case Rep Crit Care"},{"key":"bib8-20230822","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00000542-198701000-00021","article-title":"Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue","volume":"66","year":"1987","journal-title":"Anesthesiology"},{"key":"bib9-20230822","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1634\/theoncologist.2011-0372","article-title":"Hepatic artery embolization for neuroendocrine tumors: postprocedural management and complications","volume":"17","year":"2012","journal-title":"Oncologist"},{"key":"bib10-20230822","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/MEG.0b013e328300c4f3","article-title":"Case of carcinoid crisis following a fine-needle biopsy of hepatic metastasis","volume":"21","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"bib11-20230822","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1445-5994.2012.02719.x","article-title":"Carcinoid crisis induced by repeated abdominal examination","volume":"42","year":"2012","journal-title":"Intern Med J"},{"key":"bib12-20230822","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004836-200301000-00031","article-title":"Carcinoid crisis induced by external manipulation of liver metastasis","volume":"36","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"bib13-20230822","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jclinane.2016.03.008","article-title":"Development of effective prophylaxis against intraoperative carcinoid crisis","volume":"32","year":"2016","journal-title":"J Clin Anesth"},{"key":"bib14-20230822","first-page":"358","article-title":"Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis","volume":"151","year":"2016","journal-title":"Surgery"},{"key":"bib15-20230822","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/jso.23323","article-title":"Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients","volume":"107","year":"2013","journal-title":"J Surg Oncol"},{"key":"bib16-20230822","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/bja\/87.3.447","article-title":"Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours","volume":"87","year":"2001","journal-title":"Br J Anaesth"},{"key":"bib17-20230822","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jamcollsurg.2010.07.016","article-title":"Role of imaging in the preoperative staging of small bowel neuroendocrine tumors","volume":"211","year":"2010","journal-title":"J Am Coll Surg"},{"key":"bib18-20230822","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.surg.2014.08.009","article-title":"Expanded criteria for carcinoid liver debulking: Maintaining survival and increasing the number of eligible patients","volume":"156","year":"2014","journal-title":"Surgery"},{"key":"bib19-20230822","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.anclin.2017.01.021","article-title":"Pharmacology of octreotide: clinical implications for anesthesiologists and associated risks","volume":"35","year":"2017","journal-title":"Anesthesiol Clin"},{"key":"bib20-20230822","article-title":"Neuroendocrine and adrenal tumors, version 3.2018","year":"2018","journal-title":"The NCCN Guidelines"},{"key":"bib21-20230822","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","article-title":"The surgical management of small bowel neuroendocrine tumors","volume":"46","year":"2017","journal-title":"Pancreas"},{"key":"bib22-20230822","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000461583","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pre- and perioperative therapy in patients with neuroendocrine tumors","volume":"105","year":"2017","journal-title":"Neuroendocrinology"},{"key":"bib23-20230822","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2014 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","journal-title":"J Biomed Inform"},{"key":"bib24-20230822","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s00330-016-4475-3","article-title":"The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin","volume":"27","year":"2017","journal-title":"Eur Radiol"},{"key":"bib25-20230822","first-page":"4","article-title":"Neuroendocrine tumors (NETs) of unknown primary: is early surgical exploration and aggressive debulking justifiable?","volume":"5","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"bib26-20230822","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","year":"2004","journal-title":"Ann Surg"},{"key":"bib27-20230822","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/1440-1681.12594","article-title":"The role of vagal pathway and NK1 and NK2 receptors in cardiovascular and respiratory effects of neurokinin A","volume":"43","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"bib28-20230822","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00005344-200501000-00009","article-title":"Effect of substance P on venous tone in conscious rats","volume":"45","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"bib29-20230822","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/EJE-08-0196","article-title":"Tachykinins in endocrine tumors and the carcinoid syndrome","volume":"159","year":"2008","journal-title":"Eur J Endocrinol"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006676-201904000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T11:30:23Z","timestamp":1692703823000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201904000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000001271","relation":{},"ISSN":["1536-4828","0885-3177"],"issn-type":[{"value":"1536-4828","type":"electronic"},{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}